Transcription factor expression in B-cell precursor-leukemia cell lines: Preferential expression of T-bet

Akira Harashima, Yoshinobu Matsuo, Hans G. Drexler, Ayumi Okochi, Ryuichi Motoda, Mitsune Tanimoto, Kunzo Orita

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A number of transcription factors (TFs) have been reported that play crucial roles in hematopoiesis. However, only little is known about how these factors are involved in the mechanisms of hematopoietic development and lineage commitment. To investigate the roles of TFs in human B-cell precursors (BCPs), the present study analyzed the expression of the following 16 hematopoietic TFs: AML1, C/EBPα, C/EBPβ, C/EBPγ, C/EBPε, E2A, Ets-1, GATA-1, GATA-2, GATA-3, Ikaros, IRF-1, Pax5, PU.1, T-bet and TCF-1 in 30 human BCP-leukemia cell lines. All BCP-leukemia cell lines were found to be positive for the expression of AML1, C/EBPγ, E2A, Ets-1, IRF-1, Pax5 and PU.1 at the mRNA level. The mRNA expression of C/EBPα, C/EBPβ, C/EBPε, GATA-2, Ikaros, T-bet and TCF-1 was detected in 2 to 29 of the cell lines. Eight BCP-cell lines showed positivity for the dominant negative Ikaros isoform Ik6, while others were positive for expression of Ik1, 2, 3 and 4. GATA-1 and GATA-3 were universally negative. The expression of C/EBPα, PU.1 and T-bet was positive at the protein level in five, 29 and four out of 30 BCP-cell lines, respectively. Cell lines were stimulated with interleukin (IL)-7 and/or interferon (IFN)-γ to investigate the regulation of TF expression. T-bet was clearly induced in the two cell lines NALM-19 and NALM-29 after stimulation. C/EBPβ and IRF-1 were up-regulated in both cell lines and TCF-1 was down-regulated in NALM-19. No significant changes were observed for the other 12 TFs. The present report could provide useful information in the study of the role of TFs on normal and malignant human BCPs.

Original languageEnglish
Pages (from-to)841-848
Number of pages8
JournalLeukemia Research
Volume29
Issue number7
DOIs
Publication statusPublished - Jul 2005

Fingerprint

B-Cell Leukemia
Transcription Factors
Cell Line
B-Lymphoid Precursor Cells
Interleukin-7
Messenger RNA
Hematopoiesis
Interferons
Protein Isoforms

Keywords

  • B-cell precursor-leukemia
  • Cell line
  • Interferon-γ
  • Interleukin-7
  • Transcription factor

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Harashima, A., Matsuo, Y., Drexler, H. G., Okochi, A., Motoda, R., Tanimoto, M., & Orita, K. (2005). Transcription factor expression in B-cell precursor-leukemia cell lines: Preferential expression of T-bet. Leukemia Research, 29(7), 841-848. https://doi.org/10.1016/j.leukres.2004.12.010

Transcription factor expression in B-cell precursor-leukemia cell lines : Preferential expression of T-bet. / Harashima, Akira; Matsuo, Yoshinobu; Drexler, Hans G.; Okochi, Ayumi; Motoda, Ryuichi; Tanimoto, Mitsune; Orita, Kunzo.

In: Leukemia Research, Vol. 29, No. 7, 07.2005, p. 841-848.

Research output: Contribution to journalArticle

Harashima, A, Matsuo, Y, Drexler, HG, Okochi, A, Motoda, R, Tanimoto, M & Orita, K 2005, 'Transcription factor expression in B-cell precursor-leukemia cell lines: Preferential expression of T-bet', Leukemia Research, vol. 29, no. 7, pp. 841-848. https://doi.org/10.1016/j.leukres.2004.12.010
Harashima, Akira ; Matsuo, Yoshinobu ; Drexler, Hans G. ; Okochi, Ayumi ; Motoda, Ryuichi ; Tanimoto, Mitsune ; Orita, Kunzo. / Transcription factor expression in B-cell precursor-leukemia cell lines : Preferential expression of T-bet. In: Leukemia Research. 2005 ; Vol. 29, No. 7. pp. 841-848.
@article{8d39360d0e67439080f44bc5fd3190b1,
title = "Transcription factor expression in B-cell precursor-leukemia cell lines: Preferential expression of T-bet",
abstract = "A number of transcription factors (TFs) have been reported that play crucial roles in hematopoiesis. However, only little is known about how these factors are involved in the mechanisms of hematopoietic development and lineage commitment. To investigate the roles of TFs in human B-cell precursors (BCPs), the present study analyzed the expression of the following 16 hematopoietic TFs: AML1, C/EBPα, C/EBPβ, C/EBPγ, C/EBPε, E2A, Ets-1, GATA-1, GATA-2, GATA-3, Ikaros, IRF-1, Pax5, PU.1, T-bet and TCF-1 in 30 human BCP-leukemia cell lines. All BCP-leukemia cell lines were found to be positive for the expression of AML1, C/EBPγ, E2A, Ets-1, IRF-1, Pax5 and PU.1 at the mRNA level. The mRNA expression of C/EBPα, C/EBPβ, C/EBPε, GATA-2, Ikaros, T-bet and TCF-1 was detected in 2 to 29 of the cell lines. Eight BCP-cell lines showed positivity for the dominant negative Ikaros isoform Ik6, while others were positive for expression of Ik1, 2, 3 and 4. GATA-1 and GATA-3 were universally negative. The expression of C/EBPα, PU.1 and T-bet was positive at the protein level in five, 29 and four out of 30 BCP-cell lines, respectively. Cell lines were stimulated with interleukin (IL)-7 and/or interferon (IFN)-γ to investigate the regulation of TF expression. T-bet was clearly induced in the two cell lines NALM-19 and NALM-29 after stimulation. C/EBPβ and IRF-1 were up-regulated in both cell lines and TCF-1 was down-regulated in NALM-19. No significant changes were observed for the other 12 TFs. The present report could provide useful information in the study of the role of TFs on normal and malignant human BCPs.",
keywords = "B-cell precursor-leukemia, Cell line, Interferon-γ, Interleukin-7, Transcription factor",
author = "Akira Harashima and Yoshinobu Matsuo and Drexler, {Hans G.} and Ayumi Okochi and Ryuichi Motoda and Mitsune Tanimoto and Kunzo Orita",
year = "2005",
month = "7",
doi = "10.1016/j.leukres.2004.12.010",
language = "English",
volume = "29",
pages = "841--848",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Transcription factor expression in B-cell precursor-leukemia cell lines

T2 - Preferential expression of T-bet

AU - Harashima, Akira

AU - Matsuo, Yoshinobu

AU - Drexler, Hans G.

AU - Okochi, Ayumi

AU - Motoda, Ryuichi

AU - Tanimoto, Mitsune

AU - Orita, Kunzo

PY - 2005/7

Y1 - 2005/7

N2 - A number of transcription factors (TFs) have been reported that play crucial roles in hematopoiesis. However, only little is known about how these factors are involved in the mechanisms of hematopoietic development and lineage commitment. To investigate the roles of TFs in human B-cell precursors (BCPs), the present study analyzed the expression of the following 16 hematopoietic TFs: AML1, C/EBPα, C/EBPβ, C/EBPγ, C/EBPε, E2A, Ets-1, GATA-1, GATA-2, GATA-3, Ikaros, IRF-1, Pax5, PU.1, T-bet and TCF-1 in 30 human BCP-leukemia cell lines. All BCP-leukemia cell lines were found to be positive for the expression of AML1, C/EBPγ, E2A, Ets-1, IRF-1, Pax5 and PU.1 at the mRNA level. The mRNA expression of C/EBPα, C/EBPβ, C/EBPε, GATA-2, Ikaros, T-bet and TCF-1 was detected in 2 to 29 of the cell lines. Eight BCP-cell lines showed positivity for the dominant negative Ikaros isoform Ik6, while others were positive for expression of Ik1, 2, 3 and 4. GATA-1 and GATA-3 were universally negative. The expression of C/EBPα, PU.1 and T-bet was positive at the protein level in five, 29 and four out of 30 BCP-cell lines, respectively. Cell lines were stimulated with interleukin (IL)-7 and/or interferon (IFN)-γ to investigate the regulation of TF expression. T-bet was clearly induced in the two cell lines NALM-19 and NALM-29 after stimulation. C/EBPβ and IRF-1 were up-regulated in both cell lines and TCF-1 was down-regulated in NALM-19. No significant changes were observed for the other 12 TFs. The present report could provide useful information in the study of the role of TFs on normal and malignant human BCPs.

AB - A number of transcription factors (TFs) have been reported that play crucial roles in hematopoiesis. However, only little is known about how these factors are involved in the mechanisms of hematopoietic development and lineage commitment. To investigate the roles of TFs in human B-cell precursors (BCPs), the present study analyzed the expression of the following 16 hematopoietic TFs: AML1, C/EBPα, C/EBPβ, C/EBPγ, C/EBPε, E2A, Ets-1, GATA-1, GATA-2, GATA-3, Ikaros, IRF-1, Pax5, PU.1, T-bet and TCF-1 in 30 human BCP-leukemia cell lines. All BCP-leukemia cell lines were found to be positive for the expression of AML1, C/EBPγ, E2A, Ets-1, IRF-1, Pax5 and PU.1 at the mRNA level. The mRNA expression of C/EBPα, C/EBPβ, C/EBPε, GATA-2, Ikaros, T-bet and TCF-1 was detected in 2 to 29 of the cell lines. Eight BCP-cell lines showed positivity for the dominant negative Ikaros isoform Ik6, while others were positive for expression of Ik1, 2, 3 and 4. GATA-1 and GATA-3 were universally negative. The expression of C/EBPα, PU.1 and T-bet was positive at the protein level in five, 29 and four out of 30 BCP-cell lines, respectively. Cell lines were stimulated with interleukin (IL)-7 and/or interferon (IFN)-γ to investigate the regulation of TF expression. T-bet was clearly induced in the two cell lines NALM-19 and NALM-29 after stimulation. C/EBPβ and IRF-1 were up-regulated in both cell lines and TCF-1 was down-regulated in NALM-19. No significant changes were observed for the other 12 TFs. The present report could provide useful information in the study of the role of TFs on normal and malignant human BCPs.

KW - B-cell precursor-leukemia

KW - Cell line

KW - Interferon-γ

KW - Interleukin-7

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=20344397664&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20344397664&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2004.12.010

DO - 10.1016/j.leukres.2004.12.010

M3 - Article

C2 - 15927679

AN - SCOPUS:20344397664

VL - 29

SP - 841

EP - 848

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 7

ER -